Evidence map›Paper›PMID 38861324›Full record

ArticleClinical journal of the American Society of Nephrology : CJASN2024

Effects of Individualized Anemia Therapy on Hemoglobin Stability: A Randomized Controlled Pilot Trial in Patients on Hemodialysis.

Doris H Fuertinger, Lin-Chun Wang, David J Jörg, Lemuel Rivera Fuentes, Xiaoling Ye, Sabrina Casper, Hanjie Zhang, Ariella Mermelstein, Alhaji Cherif, Kevin Ho and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical journal of the American Society of Nephrology : CJASN, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Observational
  3. Festschrift in honor of Dr. Jeffrey Hymes.Frontiers in nephrology · 2025
    Article
  4. Automated Dialysis Anemia Management: Role of the Treating Nephrologist.Clinical journal of the American Society of Nephrology : CJASN · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Doris H FuertingerFresenius Medical Care Deutschland GmbH, Bad Homburg, Germany.ORCID 0000-0001-6321-2367
Lin-Chun WangRenal Research Institute, New York, New York.ORCID 0000-0003-0860-7651
David J JörgFresenius Medical Care Deutschland GmbH, Bad Homburg, Germany.ORCID 0000-0001-5960-0260
Lemuel Rivera FuentesRenal Research Institute, New York, New York.ORCID 0000-0003-2916-8985
Xiaoling YeRenal Research Institute, New York, New York.
Sabrina CasperFresenius Medical Care Deutschland GmbH, Bad Homburg, Germany.ORCID 0000-0002-9083-4329
Hanjie ZhangRenal Research Institute, New York, New York.
Ariella MermelsteinRenal Research Institute, New York, New York.ORCID 0000-0001-8881-8955
Alhaji CherifRenal Research Institute, New York, New York.
Kevin HoFresenius Medical Care North America, Waltham, Massachusetts.
Jochen G RaimannRenal Research Institute, New York, New York.ORCID 0000-0002-8954-2783
Lela TisdaleRenal Research Institute, New York, New York.
Peter KotankoRenal Research Institute, New York, New York.ORCID 0000-0003-4373-412
Stephan ThijssenRenal Research Institute, New York, New York.

Funding

Fresenius Medical Care North America
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anemiaerythropoietinhemodialysisrandomized controlled trials

Identifiers

PMID38861324
PMCPMC11390026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.